4//SEC Filing
Winningham Rick E 4
Accession 0001415889-25-014263
CIK 0001583107other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 6:44 PM ET
Size
6.3 KB
Accession
0001415889-25-014263
Insider Transaction Report
Form 4
Winningham Rick E
DirectorChief Executive Officer
Transactions
- Tax Payment
Ordinary Shares
2025-05-20$9.45/sh−15,364$145,190→ 1,762,780 total
Holdings
- 92,567(indirect: By Trust)
Ordinary Shares
- 3,900(indirect: As Custodian)
Ordinary Shares
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001302443
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 6:44 PM ET
- Size
- 6.3 KB